Showing results (71-80 of 563) with videos related to
Sort By:
Pageof 57
Psychological Medicine|August 1, 1988
The use of cholecystokinin in schizophrenia: a reviewS A Montgomery, M C GreenInternational Clinical Psychopharmacology|November 1, 1995
First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophreniaD S Baldwin, S A MontgomeryPostgraduate Medical Journal|January 1, 1980
Measurement of change in psychiatric illness: new obsessional, schizophrenia and depression scalesS A Montgomery, D B MontgomeryInternational Clinical Psychopharmacology|July 21, 1998
Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled studyJ L Terra, S A MontgomeryInternational Journal of Clinical Pharmacology Research|January 1, 1989
Pitfalls in assessing efficacy and side-effects of antidepressantsS A Montgomery, M T LambertAntimicrobial Agents and Chemotherapy|March 1, 1995
Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicansJ Fostel, D MontgomeryInternational Clinical Psychopharmacology|February 18, 1998
Social phobia: long-term treatment outcome and prediction of response--a moclobemide studyM Versiani, R Amrein, S A MontgomeryActa Psychiatrica Scandinavica. Supplementum|January 1, 1989
Why do amitriptyline and dothiepin appear to be so dangerous in overdose?S A Montgomery, D Baldwin, M GreenPageof 57